2026. Lipohypertrophy at Injection Sites: An Underexamined Cause of Unexplained Glycaemic Variability. Journal of Clinical Diabetes and Obesity. 6, 1 (Aug. 2026), 43–48. DOI:https://doi.org/10.5281/zenodo.22261640.